SD Biosensor

At a glance

SD Biosensor filed 52 disclosures in the last 12 months, including 16 insider, 4 5% holder and 1 buyback. The most recent key filing was on Sep 22.

Revenue for 2025 was ₩711B, up 2.3% on 2024. It made an operating loss of ₩80.9B. Debt was 39% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩380B and operating loss of ₩18.9B.

The 2025 annual report lists 656 employees with an average tenure of 4 years and average pay of ₩67.1M, #685 of 1,829 listed companies by average pay. Its 9 directors and auditors were paid ₩202M each on average. It paid ₩200 per common share in cash dividends, against ₩200 a year earlier (+0%). 조영식 and related parties held 71.65% at year end.

From the 2025 annual report

Staff: 656 (364 men, 292 women), of whom 30 on fixed-term contracts. Total pay for the year: ₩40.6B. Directors and auditors: 9, paid ₩1.8B in total.

Dividends (common shares)

Largest shareholder

조영식 holds 26.77%; with 20 related parties the group holds 71.65% of common shares at year end (from 70.02% at the start of the year).

Individuals paid ₩500M or more

Source: 2025 annual business report (DART). How figures are combined

Financial summary